Effect of perioperative aspirin continuation on bleeding after pneumonectomy
Qirui Chen; Yan Liu; Yi Liu; Ying Ji; Xin Ye; Xin Li; Yili Fu; Jinbai Miao · 2023 · Thoracic Cancer
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract
Abstract Background To investigate the effect of continuous oral aspirin in perioperative period on bleeding in pneumonectomy. Methods A total of 170 patients who underwent pneumonectomy in our hospital from March 2021 to March 2022 were selected as the study objects. All patients took oral aspirin before surgery and did not take other antiplatelet agent or anticoagulants at the same time. The continuation group included 85 cases and continued to take aspirin 100 mg/day during the perioperative period, and the interruption group included 85 cases who stopped aspirin for 7 days before surgery a
Abstract by Qirui Chen; Yan Liu; Yi Liu; Ying Ji; Xin Ye; Xin Li; Yili Fu; Jinbai Miao, Thoracic Cancer (2023) — licensed CC BY 4.0.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
Effects of Src on Proliferation and Invasion of Lung Cancer Cells
Negative / Null Result ReportSecretory Function of Kupffer Cells in Liver Cancer After Cryoablation
Negative / Null Result ReportEffect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain
Negative / Null Result ReportImpact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer
Negative / Null Result ReportImpact of innate lymphoid cell type 2 in chronic lymphocytic leukemia on the function of treg and CD8+ T cells through IL-9
Negative / Null Result ReportAnti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: DOAJ · DOI 10.1111/1759-7714.14846